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The diagnosis of metastases to the heart (MH) is seldom observed in clinical practice.
Literature shows that MH were observed at autopsy in histological specimens of 8.4% patients with primary neoplasms. In men
they were derived from mesothelioma, malignant melanoma, and lung carcinoma, whereas in women – from malignant
melanoma, lung and renal cancer. Sarcomas and lymphosarcomas also cause MH.
The presence of MH or their lack has significant therapeutic implications as they worsen the prognosis of survival.
Metastases to the heart, in most cases, have been diagnosed at autopsy. There are very few clinical reports dealing with
diagnosis of intravital presence of MH.
There is no description of their derivation from bile ducts in accessible literature.
We describe a case of MH in a patient aged 69 yrs. with a long-term history of arterial hypertension, after severe cerebral stroke
and pulmonary oedema with carcinoma from bile ducts (adenocarcinoma cholangiogenes). The precise final diagnosis of the
cancer type was based on microscopic examination of the samples taken at autopsy. The malignant cells indicated moderately
differentiated tubular adenocarcinoma cholangiogenes Immunohistochemical examination showed a positive reaction to
cytokeratin 19 and 7 and negative reaction to cytokeratin 20. In the heart and lung samples micrometastases of moderately
differentiated tubular adenocarcinoma were found, which allowed us to diagnose micrometastases to the heart spreading
through the coronary vessels.
The described case, as well as medical literature, shows the necessity to look for the presence of MH, even while diagnosing
malignancies, which seldom cause metastases.
Przerzuty do serca w przebiegu raka dróg ˝ó∏ciowych
(adenocarcinoma cholangiogenes)
Przerzuty do serca (MH) sà niecz´sto rozpoznawane w codziennej praktyce lekarskiej.
Dane literaturowe podajà, i˝ MH wyst´pujà w 8,4% badaƒ histologicznych tkanek pobranych autopsyjnie od chorych
z pierwotnym nowotworem. U m´˝czyzn przerzuty do serca wyst´pujà najcz´Êciej w przypadku mi´dzyb∏oniaka, czerniaka
z∏oÊliwego i raka p∏uc, a u kobiet czerniaka z∏oÊliwego, raka p∏uc i nerki. Mi´saki i ch∏oniaki z∏oÊliwe równie˝ dajà przerzuty
do serca.
ObecnoÊç MH ma znaczenie dla wyboru metody leczenia. Ich obecnoÊç pogarsza rokowanie.
W wi´kszoÊci przypadków MH sà rozpoznawane na podstawie badania poÊmiertnego. Niewiele jest opisów literaturowych
rozpoznania przerzutów do serca za ˝ycia chorego.
W dost´pnej literaturze nie ma opisu MH w przebiegu raka dróg ˝ó∏ciowych (adenocarcinoma cholangiogenes).
Artyku∏ dotyczy opisu 69-letniej chorej z rakiem dróg ˝ó∏ciowych i przerzutami do serca. Chora ta od lat mia∏a nadciÊnienie
t´tnicze, oraz przeby∏a udar mózgu i obrz´k p∏uc. Ostateczne rozpoznanie typu nowotworu zosta∏o postawione na podstawie
badania mikroskopowego tkanek pobranych w trakcie badania poÊmiertnego. Naciek nowotworowy by∏ zbudowany
z umiarkowanie zró˝nicowanego cewkowego gruczolakoraka dróg ˝ó∏ciowych. W badaniu immunohistochemicznym
stwierdzono dodatnià reakcj´ na cytokeratyn´ 19 i 7 oraz ujemnà na cytokeratyn´ 20. W skrawkach z serca i p∏uc uwidoczniono
1 Chair and Clinic of Internal Diseases, Angiology and Physical
Medicine
Centre for Laser Diagnostics and Therapy, Central Division of
Endoscopy, Division for Genetics of Neoplasms. Silesian Medical
Academy, Katowice, Poland
2 Chair of Patology
Silesian Medical Academy, Katowice, Poland
The diagnosis of metastases to the heart (MH) is seldom
made in clinical practice. The presence of MH or their
lack has great therapeutic implications. According to
Silvestri and al. [1], metastases to the heart observed at
autopsy in histological specimens are present in 8.4%
patients with primary neoplasms and are more common
in younger patients..
We report the case of MH in a patient with carci-
noma from bile ducts (adenocarcinoma cholangiogenes).
Case description
A 69-year old woman (hospital reg. no. 301/03) with
a long-term history of arterial hypertension, after severe
cerebral stroke and pulmonary oedema, with a 3-year –
earlier diagnosed hypochronic anaemia and carbohydrate
intolerance was hospitalised due to epigastric pain,
weakness, and loss of weight. The symptoms had been
increasing for 2 months. A few days before hospi-
talisation, an abdomen ultrasonographic examination had
been performed in an outpatient department. The
examination showed a great number of heterogenic and
hypoechogenic irregular structures in both liver lobes. In
the right liver lobe a 1.5 cm calcification could be
observed, as well as non-enlarged intrahepatic ducts and
the choledochus. The portal vein system had normal
dimensions and non-thickened wall gallbladder was
described which was echo-negative.
The patient had smoked 10 cigarettes per day for
20 years and had given up smoking 2 months before
hospitalisation. In family anamnesis: the patient’s father
had died due to cerebral stroke and her daughter had
breast cancer.
On admission the doctor diagnosed pain on
palpation in the right subcostal area, scoliosis in the
lumbosacral part of the vertebral column, asymmetry of
tendon reflexes (L > R), considerable hypoacusis and
slowness of the cognitive processes (26 points MMSE
scale). Laboratory results showed: leucocytosis (14 600
l/ml), slight hypochromia and microcytosis of erythrocytes.
The erythrocyte count and the hemoglobin level were
normal. Serum aminotranspherases, alkaline phos-
phathase and gammaglutamyl-transpeptidase activity were
increased.
Urinalysis showed trace amounts of protein.
The serum level of the Ca 125 antigen was over 600
U/ml (normal: 35 U/ml) and the level of alphafetoprotein
was within normal range. The blood glucose curve was
incorrect.
ECG showed a regular sinus rhythm of 72 bpm,
slight depression of the ST segment, flat (+-) T wave in
leads I, aVL,V6 and a 2 mm ST segment depresson in
leads V4 and V5. Ultrasonocardiographic examination
revealed: dilatation of both the left cardiac cavities,
thickening of the interventricular septum, impaired
diastolic compliance of the left ventricle, III/IV degree
mitral insufficiency, 1st degree aortic insufficiency and
2nd degree tricuspid insufficiency, as well as thickening of
the mitral leaflets. During this examination the
hypokinesis of the whole heart was registered with EF
of 40%.
Chest X-ray examination revealed higher lung
markings, especially in lower parts; the silhouette of the
heart was adequate to the patient’s age.
Gastritis was observed on endoscopy and an obser-
vable polyp (of 1cm) on a short pedicle in the the first
part of the sigmoid was found during coloscopy.
For the first six days of hospitalisation the patient
was in good overall condition. Then, over a few hours, the
abdominal pain increased, the patient showed symptoms
of hepatic failure, acute renal insufficiency, shock,
pulmonary oedema, and disseminated intravascular
coagulation with evident anaemia. On physical exami-
nation her abdomen was tense and flatulent. Lacerating
pain was present in the epigastrium. Laboratory
examination showed the aminotranspherase activity of
a few thousand U/ml.
ECG registered ST depression of 6 mm in the
precordial leads (from V2 to V6) and negative T waves in
II, III, aVF, V3-V6 leads.
Despite intensified treatment the patient died.
Neoplasma (suspected as primary carcinoma of the
liver) was diagnosed in macroscopic autopsy. Symptoms
of haemorrhagic diathesis in the brain, stomach and
intestines, pulmonary and cerebral oedema and shock
kidney were an additive finding. On addition we observed
intensified atherosclerosis of the aortal arcus and the
abdominal aorta.
The hepatic tumor was multifocal, with widely
distributed greyish-white nodules of variable size involving
the entire liver. Microscopically, the carcinoma cells
indicated moderately differentiated tubular adeno-
carcinoma cholangiogenes (Figure 1). Immunohisto-
chemical examination showed a positive reaction to
cytokeratin 19 and 7 (Figure 2) and a negative reaction to
cytokeratin 20 (Figure 3). In the heart (Figure 4) and
lung (Figure 5) samples we found micrometastases of
moderately differentiated tubular adenocarcinoma.
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mikroprzerzuty umiarkowanie zró˝nicowanego gruczolakoraka cewkowego. Rozpoznano mikroprzerzuty do serca, szerzàce si´
drogà naczyƒ wieƒcowych.
Opisany przypadek, a tak˝e dane literaturowe wskazujà na koniecznoÊç poszukiwania obecnoÊci MH nawet wtedy, kiedy
u chorego wyst´puje nowotwór rzadko powodujàcy przerzuty.
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Microscopic examination showed carcinoma of the
bile ducts (adenocarcinoma cholangiogenes). The heart
and lung samples were also taken for microscopy. In both
those organs we discerned the presence of adeno-
carcinoma micrometastases. The immonohistochemical
staining of these samples was not performed as material
with micrometastases was not avalaible.
Discussion
Metastases to the heart are more frequent than primary
heart neoplasms and their occurrence worsens life
prognosis.
Metastases to the heart and pericardium spread in
four ways: retroactively through lymphatic vessels, with
either the arterial or the venous blood stream, and by
direct infiltration [2]. Silvestrii and al. [1] observed during
autopsy, that in men metastases to the heart are derived
from mesothelioma, malignant melanoma, and lung
carcinoma (100%, 50% and 31% respectively), whereas in
women – from malignant melanoma, lung and renal
cancer (42%, 26% and 20% respectively). Sarcomas
and lymphosarcomas also cause metastases to the heart
[2-6].
There is no description of MH derivation from bile
ducts in accessible literature. Metastases to the heart, in
most cases, have been diagnosed at autopsy [1, 2, 4, 7].
There are very few clinical reports dealing with the
intravital diagnosis of metastases to the heart [2-6, 8].
The location of metastases can be in the endocardium, in
the valvular endocardium, the myocardium and the peri-
cardium.
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Figure 1. Photomicrograph of the liver tumor shows moderately
differentiated tubular adenocarcinoma (HE;200x)
Figure 2. Photomicrograph of the liver tumor shows positive
cytokeratin 7 staining (CK7;200x)
Figure 3. Photomicrograph of the liver tumor shows negative
cytokeratin 20 staining (CK20;200x)
Figure 4. Photomicrograph of the myocardium shows adenocarcinoma
micrometastases (HE;200x)
Figure 5. Photomicrograph of the lung shows adenocarcinoma
metastases (HE;100X)
MH can cause elevation of the ST segment, which
should compel the doctors to differentiate between its
MH origin and myocardial ischaemia [8]. If the MH are
located in the left heart atrium, they can cause, or be
symptomatic of, mitral stenosis [5]. Rupture of the right
atrium induced by MH causes cardiac tamponade [4].
Atrial fibrillation, peripheral embolisms (3), heart failure
and chest pain (2) were also described in literature.
X-ray examination, ultrasonocardiography, computer
tomography and magnetic resonance imaging are all
helpful in the diagnostic processes [2, 5, 6].
In this particular case the diagnosis of MH was
stated during autopsy.
Disorders in ECG examination occurring during the
patient’s life could be connected to earlier, carelessly
treated arterial hypertention with organic complications
including acute left ventricular failure.
The multiorgan insufficiency, directly causing death,
was probably due to the progression of neoplastic disease,
while the massive dissemination of neoplasmatic cells
before the patient’s death could have caused the
intensified ECG disorders.
The precise final diagnosis of the type of cancer was
based on microscopic examination which allowed us to
discern micrometastases to the heart spreading through
coronary vessels.
The described case, as well as medical literature,
show the necessity to look for the presence of MH, even
while diagnosing those neoplasms which seldom cause
metastases. The presence of metastases to the heart
directly implicates the choice of medical treatment and
survival prognosis.
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